StockSignal
How to use the screener's diagnostic stories to distinguish genuine organic growth from growth manufactured by mechanisms that do not reflect business expansion.
The Question
Is this growth real? Growth is the most sought-after characteristic in screening, and the Consistent Growth article helps you find it — Consistent Grower, Earnings Acceleration, Growth With Volume Support. But growth has a quality dimension that headline numbers do not reveal. A company can show 15% EPS growth entirely because it bought back shares, not because its business grew. It can show 20% revenue growth entirely from acquisitions, with organic revenue flat or declining. It can show accelerating revenue by pulling forward future demand through aggressive discounting or channel stuffing.
This article is the diagnostic counterpart to Consistent Growth. Where that guide answers "find me growing companies," this one answers "can I trust the growth I found?" The stories here decompose headline growth into its structural components — separating organic from inorganic, sustainable from manufactured, and genuine acceleration from timing artifacts.
What Manufactured Growth Looks Like Structurally
Manufactured growth is growth that appears in headline metrics but does not reflect genuine expansion of the underlying business. It takes several common forms, each with a distinct structural signature.
Buyback-inflated EPS occurs when the share count shrinks faster than the business grows. Earnings per share rise because the denominator is decreasing, not because total earnings are increasing. The company may be stagnating or even declining in absolute terms while showing per-share growth.
Acquisition-driven revenue occurs when headline revenue growth is primarily or entirely from acquired companies. The legacy business may be flat or shrinking. The growth number is real in an accounting sense — the revenue exists — but it does not reflect organic demand expansion. Acquisition-driven growth is less predictable, often lower-margin, and subject to integration risk.
Pull-forward revenue occurs when current-period revenue is inflated by demand borrowed from future periods — through aggressive discounting, early shipment of orders, or promotional activity that shifts timing without creating new demand. The growth looks real until the following period, when the pulled-forward demand creates a gap.
The screener's diagnostic stories identify each of these patterns by comparing headline growth metrics against their structural composition. The question is always the same: what is actually driving this number?
Key Signals
Organic Growth Rate
What it measures: Revenue growth from the company's existing operations, excluding the contribution of acquisitions. When total revenue growth is 20% but organic growth is 3%, 85% of the growth came from buying other companies. This signal isolates the growth that the company's own business generated, which is the most sustainable and predictable component.
Data source: Total revenue growth adjusted for the revenue contribution of businesses acquired during the measurement period.
EPS vs. Total Earnings Trajectory
What it measures: The divergence between earnings per share growth and total net income growth. When EPS grows faster than total earnings, the difference is explained by share count reduction — buybacks are contributing to per-share growth. The wider the gap, the more the EPS story depends on capital structure engineering rather than business performance.
Data source: Comparison of diluted EPS growth rate against total net income growth rate over corresponding periods.
Revenue Quality
What it measures: The sustainability characteristics of reported revenue — whether revenue is growing from durable sources (recurring contracts, expanding customer base) or transient sources (one-time sales, channel loading, promotional activity). Revenue quality separates growth that is likely to persist from growth that may reverse in subsequent periods.
Data source: Analysis of revenue composition, deferred revenue trends, customer retention metrics, and receivables growth relative to revenue growth.
Stories That Emerge
Apparent EPS Growth, Structural Buyback Dependence
What it identifies: Companies where earnings per share are growing primarily because the share count is declining through buybacks, not because the business is generating more total earnings. When EPS growth significantly exceeds total earnings growth, the per-share improvement is a capital allocation artifact. Investors relying on EPS growth as evidence of business expansion are seeing a reflection of treasury activity, not operational performance.
Limits: Buyback-enhanced EPS growth is not inherently bad. If the buybacks are well-timed (at low valuations) and funded by genuine free cash flow, they create real value for remaining shareholders. The diagnostic identifies the structural dependence on buybacks for EPS growth, not whether the buyback strategy is sound.
Apparent Revenue Growth, Structural Acquisition Dependence
What it identifies: Companies showing headline revenue growth that is primarily driven by acquisitions rather than organic business expansion. When total revenue growth is strong but organic growth is flat or declining, the growth narrative depends on the company's ability to continue acquiring — which introduces deal pipeline risk, integration risk, and often margin dilution that headline numbers obscure.
Limits: Acquisition-driven growth is a legitimate strategy in fragmented industries where consolidation creates real value. The diagnostic identifies the structural composition of growth without evaluating the strategic logic. Some acquisition-dependent growth is highly productive; some is a substitute for organic stagnation.
Apparent Revenue Acceleration, Structural Pull-Forward
What it identifies: Companies where revenue is accelerating in the current period due to demand that has been pulled forward from future periods — through promotional activity, early order fulfillment, or channel loading. The acceleration looks like genuine business momentum, but the structural driver is timing rather than expanding demand. The telltale sign is often a combination of revenue acceleration with declining backlog, increasing receivables, or rising deferred revenue drawdowns.
Limits: Distinguishing genuine demand acceleration from pull-forward is difficult with quantitative signals alone. Seasonal patterns, new product launches, and contract timing can all create legitimate revenue concentration. The diagnostic identifies the structural indicators of pull-forward without certainty about the cause.
Apparent Growth, Structural Margin Erosion
What it identifies: Companies showing revenue growth that is accompanied by margin compression. When a company grows revenue by cutting prices, accepting lower-margin business, or investing heavily in customer acquisition, the top line expands while profitability per dollar of revenue declines. This growth-margin trade-off may be strategic (investing for scale) or may indicate that the company can only grow by sacrificing profitability — a structurally different situation than growth with stable or expanding margins.
Limits: Many successful growth strategies involve a deliberate period of margin compression — investing in market share that may eventually produce margin expansion. The diagnostic captures the current structural pattern without determining whether the margin sacrifice is temporary and strategic or permanent and problematic.
Using the Screener
Standalone Diagnostic: Mapping Manufactured Growth
Run Apparent EPS Growth, Structural Buyback Dependence as a standalone screen to identify all companies in your universe where per-share growth is driven by share count reduction rather than business expansion. Separately, run Apparent Revenue Growth, Structural Acquisition Dependence to map companies where top-line growth is acquisition-driven. These two screens together reveal the landscape of manufactured growth — companies that appear to be growing but are engineering that appearance through capital allocation rather than operational expansion.
Overlay Workflow: Validating Consistent Growth Results
Start with the positive screen from the Consistent Growth guide — select Consistent Grower or Earnings Acceleration to find companies with strong growth patterns. Then overlay diagnostic stories on those results. Check for Apparent EPS Growth, Structural Buyback Dependence to identify growth candidates where EPS improvement is buyback-driven. Check for Apparent Revenue Acceleration, Structural Pull-Forward to identify candidates where recent acceleration may be a timing artifact. Check for Apparent Growth, Structural Margin Erosion to identify candidates growing revenue at the cost of profitability. Companies that pass Consistent Grower and do not trigger any diagnostic stories show growth that is organic, sustainable, and profitable — the highest-confidence growth profile.
Boundaries
What This Cannot Tell You
Growth quality diagnostics identify the structural composition of current growth — what is driving it and whether the drivers are organic or manufactured. They do not predict whether growth will continue. A company with entirely organic, margin-accretive growth can still decelerate. A company with acquisition-dependent growth can successfully integrate and generate organic growth from its expanded base. The diagnostics describe current structural reality, not future trajectory.
These stories also cannot fully assess management strategy. Buyback-driven EPS growth may be part of a deliberate, value-creating capital return strategy. Acquisition-driven revenue growth may reflect a well-executed consolidation plan. Margin compression during growth may be a rational investment in future profitability. The diagnostics identify the structural pattern — the strategic evaluation requires qualitative judgment about management, industry dynamics, and competitive context.
Finally, growth composition analysis is most informative when applied over multiple periods. A single quarter of acquisition-driven growth or buyback-enhanced EPS does not establish a structural pattern. The diagnostic stories are designed to flag persistent structural conditions, but point-in-time screens may capture temporary conditions that do not reflect the company's dominant growth mode.